Company intelligence / Profile preview

Velsera

Boston, MA, United Statesvelsera.com ↗

Ownership: Private
Development stage: Commercial

Overview

Velsera offers commercial-stage software platforms that accelerate clinical genomics workflows and multiomic data analysis. Their CGW Plus platform streamlines variant assessment and reporting for clinical labs. The company’s integrated solutions are widely adopted by top pharma companies and diagnostic labs globally to improve R&D productivity and patient outcomes in precision medicine.

Therapeutic areas: OncologyRare DiseasesOther
Modalities: Multiomics data analysis (genomics, transcriptomics, etc.)Companion diagnostics developmentNGS assay development and validation
Industry: Digital Health Medical Devices

Partnerships

Major pharmaceutical companiesClinical diagnostic labs worldwide

Beyond the preview

Go deeper on Velsera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Velsera.

Explore the full profile